Enhancing chemo-immunotherapy in triple-negative breast cancer: Co-delivery of doxorubicin and berberine using nanoparticles to downregulate PD-L1 and eliminate cancer stem cells

Autor: Shi, Yonghui a, b, 1, Cao, Linhui c, 1, Zhao, Wenxia a, 1, Lai, Songgui d, 1, Chen, Ziying d, Ye, Zicong a, Guo, Ming a, He, Jianxiong a, Zhou, Yuehan d, ⁎, Li, Guocheng a, ⁎⁎, Lv, Li a, ⁎⁎⁎
Zdroj: In International Journal of Pharmaceutics 10 February 2025 670
Databáze: ScienceDirect